The immunogenetics of SLE.
D000818:Animals; D000974:Antibodies, Antinuclear / Q000235:genetics / Q000276:immunology; D001323:Autoantibodies / Q000096:biosynthesis / Q000235:genetics; D005260:Female; D005787:Gene Frequency; D005802:Genes, MHC Class II; D006680:HLA Antigens / Q000235:genetics* / Q000276:immunology*; D015235:HLA-B Antigens; D015236:HLA-C Antigens; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000235:genetics* / Q000276:immunology*; D008297:Male; D051379:Mice; D008814:Mice, Inbred NZB; D014176:Protein Biosynthesis; D012190:Retroviridae / Q000235:genetics / Q000276:immunology
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D006680:HLA Antigens; D015235:HLA-B Antigens; D015236:HLA-C Antigens; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D006830:Hydralazine